Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03847428 |
|---|---|
| Brief Title: | Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment (EMERALD-2) |
| First Submitted : | February 18, 2019 |
| First Submitted that Met QC Criteria : | February 18, 2019 |
| First Posted : | February 20, 2019 |
| Last Update Submitted that Met QC Criteria : | February 17, 2023 |
| Last Update Posted : | February 21, 2023 |